Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony T Tan

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Journal of Hepatology|June 12, 2023
Comment on 'End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN-based therapy in patients with CHB'Antonio Bertoletti, Nina Le Bert, Anthony T Tan, et al.
Journal of Virology|December 7, 2018
Spatiotemporal Differences in Presentation of CD8 T Cell Epitopes during Hepatitis B Virus InfectionAtefeh Khakpoor, Yi Ni, Antony Chen, et al.
Cell Reports. Medicine|November 18, 2020
Hepatitis Delta Virus Acts as an Immunogenic Adjuvant in Hepatitis B Virus-Infected HepatocytesChristine Y L Tham, Janine Kah, Anthony T Tan, et al.
Cell Reports. Medicine|October 18, 2022
A comparative characterization of SARS-CoV-2-specific T cells induced by mRNA or inactive virus COVID-19 vaccinesJoey Ming Er Lim, Shou Kit Hang, Smrithi Hariharaputran, et al.
Hepatology (Baltimore, Md.)|November 29, 2020
Immunosuppressive Drug-Resistant Armored T-Cell Receptor T Cells for Immune Therapy of HCC in Liver Transplant PatientsMorteza Hafezi, Meiyin Lin, Adeline Chia, et al.
Cell Reports|January 31, 2021
Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patientsAnthony T Tan, Martin Linster, Chee Wah Tan, et al.
Journal of Hepatology|September 3, 2013
Reduction of HBV replication prolongs the early immunological response to IFNα therapyAnthony T Tan, Long Truong Hoang, Daniel Chin, et al.
Journal of Hepatology|June 23, 2025
Rapid whole-blood immune profiling reveals heterogeneous HBV-specific T cell response patterns independent of clinical disease phasesNina Le Bert, Apostolos Koffas, Rajneesh Kumar, et al.
Plos Pathogens|June 27, 2014
Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liverJuandy Jo, Anthony T Tan, James E Ussher, et al.
European Journal of Immunology|January 3, 2013
Conditional ligands for Asian HLA variants facilitate the definition of CD8+ T-cell responses in acute and chronic viral diseasesCynthia X L Chang, Anthony T Tan, Ming Yan Or, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Journal of Hepatology|June 12, 2023
Comment on 'End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN-based therapy in patients with CHB'Antonio Bertoletti, Nina Le Bert, Anthony T Tan, et al.
Journal of Virology|December 7, 2018
Spatiotemporal Differences in Presentation of CD8 T Cell Epitopes during Hepatitis B Virus InfectionAtefeh Khakpoor, Yi Ni, Antony Chen, et al.
Cell Reports. Medicine|November 18, 2020
Hepatitis Delta Virus Acts as an Immunogenic Adjuvant in Hepatitis B Virus-Infected HepatocytesChristine Y L Tham, Janine Kah, Anthony T Tan, et al.
Cell Reports. Medicine|October 18, 2022
A comparative characterization of SARS-CoV-2-specific T cells induced by mRNA or inactive virus COVID-19 vaccinesJoey Ming Er Lim, Shou Kit Hang, Smrithi Hariharaputran, et al.
Hepatology (Baltimore, Md.)|November 29, 2020
Immunosuppressive Drug-Resistant Armored T-Cell Receptor T Cells for Immune Therapy of HCC in Liver Transplant PatientsMorteza Hafezi, Meiyin Lin, Adeline Chia, et al.
Cell Reports|January 31, 2021
Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patientsAnthony T Tan, Martin Linster, Chee Wah Tan, et al.
Journal of Hepatology|September 3, 2013
Reduction of HBV replication prolongs the early immunological response to IFNα therapyAnthony T Tan, Long Truong Hoang, Daniel Chin, et al.
Journal of Hepatology|June 23, 2025
Rapid whole-blood immune profiling reveals heterogeneous HBV-specific T cell response patterns independent of clinical disease phasesNina Le Bert, Apostolos Koffas, Rajneesh Kumar, et al.
Plos Pathogens|June 27, 2014
Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liverJuandy Jo, Anthony T Tan, James E Ussher, et al.
European Journal of Immunology|January 3, 2013
Conditional ligands for Asian HLA variants facilitate the definition of CD8+ T-cell responses in acute and chronic viral diseasesCynthia X L Chang, Anthony T Tan, Ming Yan Or, et al.
Pageof 5